Advertisement
News
Advertisement

Hologic wins FDA approval of HPV genotyping test

Tue, 10/16/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Hologic Inc., of Bedford (NASDAQ: HOLX) today announced that the FDA has approved its new test for genotyping the specific human papillomavirus (HPV) types associated with the majority of invasive cervical cancers worldwide.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading